![Roy Lobb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy Lobb
Gründer bei
Aleta Biotherapeutics, Inc.
Profil
Roy R.
Lobb was the founder of Mercator Therapeutics, Inc., founded in 2009, where the title held was Chairman & Chief Scientific Officer from 2009 to 2012.
Dr. Lobb is the founder of Aleta Biotherapeutics, Inc., founded in 2015, holding the title of Director since 2015.
Dr. Lobb was the founder of Avila Therapeutics, Inc., founded in 2007, with the title of Director from 2009 to 2010.
Current jobs include Senior Director-Inside Sales at PartsSource, Inc. since 2013 and Venture Partner at Advent Venture Partners LLP since 2015.
Former jobs include Principal at Biogen MA, Inc., Consultant at Biogen, Inc., Consultant at Alnylam Pharmaceuticals, Inc., and Principal at Abingworth Management, Inc.
Aktive Positionen von Roy Lobb
| Unternehmen | Position | Beginn |
|---|---|---|
PartsSource, Inc.
 PartsSource, Inc. Packaged SoftwareTechnology Services Operates as a B2B vertical marketplace and supply chain software platform | Vertrieb & Marketing | 21.01.2010 |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Private Equity Investor | 01.08.2015 |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Gründer | 01.01.2015 |
Ehemalige bekannte Positionen von Roy Lobb
| Unternehmen | Position | Ende |
|---|---|---|
Mercator Therapeutics, Inc.
 Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer drugs | Gründer | 11.04.2012 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Corporate Officer/Principal | - |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Mercator Therapeutics, Inc.
Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer drugs | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Abingworth Management, Inc.
Abingworth Management, Inc. Investment ManagersFinance Acts as an alternative investment manager | Finance |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs | Health Technology |
PartsSource, Inc.
PartsSource, Inc. Packaged SoftwareTechnology Services Operates as a B2B vertical marketplace and supply chain software platform | Technology Services |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops cell therapy solutions for cancers and transforms cellular therapeutics to allow a broader spectrum of cancer indications | Commercial Services |
